Hypothetical Conservative Combination Protocol A conservative approach to combining these peptides would likely involve: Phase 1: Tirzepatide Establishment (Weeks 1-12) Week 1-4: Tirzepatide 2.5 mg weekly Week 5-8: Tirzepatide 5 mg weekly Week 9-12: Tirzepatide 7.5 mg weekly Cagrilintide: None (establish baseline tolerance) Phase 2: Cagrilintide Introduction (Weeks 13-20) Week 13-16: Tirzepatide 7.5 mg + Cagrilintide 0.6 mg weekly Week 17-20: Tirzepatide 7.5 mg + Cagrilintide 1.2 mg weekly Phase 3: Optimization (Week 21+) Tirzepatide 10-12.5 mg + Cagrilintide 2.4 mg weekly Adjust based on tolerance and response "The key principle when considering any peptide combination is sequential introduction with careful monitoring of tolerability markers, particularly gastrointestinal symptoms that could compound across mechanisms." This theoretical framework prioritizes safety through staged introduction, though actual clinical protocols would require medical supervision and monitoring

If you're curious about which supplements might be right for you, we invite you to take our AI quiz to find personalized recommendations tailored to your wellness journey
Each order includes 1 vial containing the 80 mg four-peptide blend (GHK-Cu, BPC-157, TB-500, KPV)
L-carnitine is generally considered safe for most adults when taken in recommended dosages [15]
A doctors evaluation ensures the treatment is safe for individual health conditions.
Pills come with moisture-proof, child-lock protective caps to preserve efficacy and deliver high-quality results each time you take